1. Academic Validation
  2. Thiamine-responsive megaloblastic anemia syndrome

Thiamine-responsive megaloblastic anemia syndrome

  • Int J Hematol. 2010 Oct;92(3):524-6. doi: 10.1007/s12185-010-0681-y.
Ali Bay 1 Mehmet Keskin Samil Hizli Hatice Uygun Alper Dai Fatma Gumruk
Affiliations

Affiliation

  • 1 Department of Pediatrics, Division of Pediatric Hematology, Gaziantep University, Gaziantep, Turkey. abay1968@yahoo.com
Abstract

Thiamine-responsive megaloblastic anemia (TRMA) syndrome usually associated with diabetes mellitus, anemia and deafness, due to mutations in SLC19A2, encoding a thiamine transporter protein. The onset of disease is usually seen during infancy or at early childhood and most of the TRMA patients are originated from consanguineous families. In this case, we report a 5-month-old boy who had diagnosis of TRMA during evaluations for his anemia and thrombocytopenia. The diagnosis of TRMA should be kept in mind in differential diagnosis of megaloblastic anemia especially in the populations where the consanguinity is frequent.

Figures